1. Home
  2. RGNX vs ACCO Comparison

RGNX vs ACCO Comparison

Compare RGNX & ACCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • ACCO
  • Stock Information
  • Founded
  • RGNX 2008
  • ACCO 1893
  • Country
  • RGNX United States
  • ACCO United States
  • Employees
  • RGNX N/A
  • ACCO 5000
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • ACCO Publishing
  • Sector
  • RGNX Health Care
  • ACCO Consumer Discretionary
  • Exchange
  • RGNX Nasdaq
  • ACCO Nasdaq
  • Market Cap
  • RGNX 445.5M
  • ACCO 353.3M
  • IPO Year
  • RGNX 2015
  • ACCO N/A
  • Fundamental
  • Price
  • RGNX $8.82
  • ACCO $3.98
  • Analyst Decision
  • RGNX Strong Buy
  • ACCO Buy
  • Analyst Count
  • RGNX 8
  • ACCO 1
  • Target Price
  • RGNX $28.50
  • ACCO $6.00
  • AVG Volume (30 Days)
  • RGNX 687.5K
  • ACCO 572.3K
  • Earning Date
  • RGNX 08-07-2025
  • ACCO 07-31-2025
  • Dividend Yield
  • RGNX N/A
  • ACCO 7.63%
  • EPS Growth
  • RGNX N/A
  • ACCO N/A
  • EPS
  • RGNX N/A
  • ACCO 0.49
  • Revenue
  • RGNX $155,782,000.00
  • ACCO $1,581,200,000.00
  • Revenue This Year
  • RGNX $327.08
  • ACCO N/A
  • Revenue Next Year
  • RGNX N/A
  • ACCO $2.11
  • P/E Ratio
  • RGNX N/A
  • ACCO $8.02
  • Revenue Growth
  • RGNX 74.95
  • ACCO N/A
  • 52 Week Low
  • RGNX $5.04
  • ACCO $3.32
  • 52 Week High
  • RGNX $13.48
  • ACCO $6.44
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 53.29
  • ACCO 58.97
  • Support Level
  • RGNX $7.83
  • ACCO $3.82
  • Resistance Level
  • RGNX $9.24
  • ACCO $4.05
  • Average True Range (ATR)
  • RGNX 0.51
  • ACCO 0.11
  • MACD
  • RGNX 0.08
  • ACCO 0.02
  • Stochastic Oscillator
  • RGNX 77.37
  • ACCO 83.33

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About ACCO Acco Brands Corporation

ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through two segments: ACCO Brands Americas, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands America segment.

Share on Social Networks: